Commentary on ‘Gender differences in clinical registration trials; is there a real problem?’ by Labots et al .-Reference-Cited by-同舟云学术

Commentary on ‘Gender differences in clinical registration trials; is there a real problem?’ by Labots et al .

Published:2018-05-31 Issue:8 Volume:84 Page:1639-1640
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Gispen-de Wied Christine¹^ORCID,de Boer Anthonius¹^ORCID

Affiliation:

1. Medicines Evaluation Board; Utrecht The Netherlands

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bcp.13620/fullpdf

Reference8 articles.

1. Parliament of the European Union DIRECTIVE 2001/20/EC https://ec.europa.eu/health/sites/health/files/files/eudralex/vol-1/dir_2001_20/dir_2001_20_en.pdf

2. European Medicines Agency Ich - gender considerations in the conduct of clinical trials https://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2010/01/WC500059887.pdf

3. Gender differences in coronary heart disease;Maas;Neth Heart J,2010

4. Gender differences in clinical registration trials: is there a real problem?;Labots;Br J Clin Pharmacol,2018

5. Early nonresponse in the antipsychotic treatment of acute mania: a criterion for reconsidering treatment? Results from an individual patient data meta-analysis;Welten;J Clin Psychiatry,2016

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Outcome differences by sex in oncology clinical trials;Nature Communications;2024-03-23

2. The Next Frontier in Health Disparities—A Closer Look at Exploring Sex Differences in Glioma Data and Omics Analysis, from Bench to Bedside and Back;Biomolecules;2022-08-30

3. Sex Proportionality in Pre-clinical and Clinical Trials: An Evaluation of 22 Marketing Authorization Application Dossiers Submitted to the European Medicines Agency;Frontiers in Medicine;2021-03-11